Sökning: WFRF:(Bitzer M.)
> (2006-2009) >
Efficacy, acceptabi...
Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 mug of ethinyl estradiol and 3 mg of drospirenone
-
Ahrendt, Hans-Joachim (författare)
-
Nisand, Israel (författare)
-
Bastianelli, C. (författare)
-
visa fler...
-
Gomez, M. A. (författare)
-
- Gemzell-Danielsson, K. (författare)
- Karolinska Institutet
-
Urdl, W. (författare)
-
Karskov, B. (författare)
-
Oeyen, L. (författare)
-
Bitzer, J. (författare)
-
Page, G. (författare)
-
- Milsom, Ian, 1950 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences
-
visa färre...
-
(creator_code:org_t)
- Elsevier BV, 2006
- 2006
- Engelska.
-
Ingår i: Contraception. - : Elsevier BV. - 0010-7824. ; 74:6, s. 451-457
- Relaterad länk:
-
https://gup.ub.gu.se...
-
visa fler...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- PURPOSE: This randomized multicenter, open-label, trial compared efficacy, acceptability, tolerability and compliance of NuvaRing with a combined oral contraceptive (COC), containing 30 mug of ethinyl estradiol (EE) and 3 mg of drospirenone. METHOD: In this 13-cycle study, 983 women were randomized and treated (intent-to-treat population) with NuvaRing or COC. RESULTS: One in-treatment pregnancy occurred with NuvaRing (Pearl Index=0.25) (95% confidence interval [CI]: 0.006, 1.363) and four with the COC (Pearl Index=0.99) (95% CI: 0.269, 2.530). For both groups, compliance (89.2% NuvaRing, 85.5% COC) and satisfaction (84% NuvaRing; 87% COC) were high; the vast majority of women found NuvaRing easy to insert (96%) and remove (97%). Tolerability was similar; the most frequent adverse events with NuvaRing were related to ring use, whereas estrogen-related events were more common with the COC. CONCLUSION: NuvaRing has comparable efficacy and tolerability to a COC containing 30 mug of EE and 3 mg drospirenone. User acceptability of both methods was high.
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Ahrendt, Hans-Jo ...
-
Nisand, Israel
-
Bastianelli, C.
-
Gomez, M. A.
-
Gemzell-Danielss ...
-
Urdl, W.
-
visa fler...
-
Karskov, B.
-
Oeyen, L.
-
Bitzer, J.
-
Page, G.
-
Milsom, Ian, 195 ...
-
visa färre...
- Artiklar i publikationen
-
Contraception
- Av lärosätet
-
Göteborgs universitet
-
Karolinska Institutet